MusculoskeletalICD-10: M81About 10 million Americans have osteoporosis; 44 million have low bone density

Osteoporosis

Also known as: Brittle Bone Disease (colloquial), Low Bone Density

Osteoporosis is a systemic skeletal disorder characterized by decreased bone density and deterioration of bone microarchitecture, leading to increased bone fragility and fracture risk. Often called a 'silent disease,' osteoporosis typically has no symptoms until a fracture occurs. The most common fracture sites are the spine, hip, and wrist, and hip fractures in particular carry significant mortality risk in older adults.

Last updated October 31, 2026

Understanding Osteoporosis

Osteoporosis is bone that has become porous and weak enough to break under loads healthy bone shrugs off: a fall from standing height, a cough, lifting a grandchild. It is defined on a DEXA scan as a T-score of -2.5 or lower, meaning density 2.5 standard deviations below a healthy young adult's, and clinically by any hip or spine fracture after minimal trauma. One in three women and one in five men over 50 will have an osteoporotic fracture. The disease is silent until something breaks, and the first break is the warning: a vertebral fracture raises the risk of another five-fold within a year, and a hip fracture carries a 20 to 25% one-year mortality in older adults.

Bone is living tissue, continuously torn down by osteoclasts and rebuilt by osteoblasts, with the whole skeleton replaced about every ten years. Peak bone mass arrives around 30, after which resorption slowly outpaces formation. In women the fall in estrogen at menopause removes the main brake on osteoclasts, and bone can be lost at 2 to 3% a year for five to seven years after periods stop; men lose it more gradually as testosterone and estrogen decline. The loss is not only quantity: the internal honeycomb thins and its struts disconnect, so strength falls faster than density suggests. Low calcium and vitamin D, glucocorticoids, thyroid excess, smoking, heavy drinking, inactivity and conditions such as celiac disease and rheumatoid arthritis all accelerate the process.

Conventional care starts from fracture-risk calculators such as FRAX rather than density alone. Bisphosphonates (alendronate, risedronate, zoledronic acid) slow osteoclasts and cut vertebral fractures by about half and hip fractures by 40 to 50% over three years; after five years most people take a drug holiday because benefit persists while the rare risks of atypical femur fracture (about 1 in 1,000 long-term users) and jaw osteonecrosis (nearer 1 in 10,000) rise with time. Denosumab, a twice-yearly injection, cuts vertebral fractures by 68% and hip fractures by 40%, but must never simply be stopped, because bone loss rebounds within months and vertebral fractures cluster. For severe disease, the bone-building agents teriparatide, abaloparatide and romosozumab add new bone and are followed by an antiresorptive to lock in the gain. Menopausal hormone therapy also prevents fractures in women using it for other reasons.

Natural approaches are the foundation every drug trial was built on, not an alternative to the drugs. Calcium and vitamin D together have the best evidence, cutting fractures by about 12% in a 29-trial meta-analysis of older adults and considerably more in those who were deficient and took them reliably, which is why every fracture trial gave them to both arms. Vitamin K2, collagen peptides, magnesium and omega-3 have plausible mechanisms and small or mixed trials; they can nudge density by a percent or two but none has shown fracture prevention alone, and strontium is a special case discussed below. Exercise is the exception: high-intensity resistance and impact training builds spine density about 3% in eight months and balance training cuts falls by roughly a quarter in randomized trials. With osteopenia and low fracture risk, lifestyle and nutrition are the whole plan; after a fragility fracture or at high FRAX risk, they accompany medication rather than replace it.

The thing most people get wrong is chasing the T-score with calcium tablets. Density is only part of fracture risk; falls cause most hip fractures, and calcium beyond about 1,200 mg a day from all sources does nothing for bone while raising the chance of kidney stones and, in some analyses, heart events. Count the calcium in your food first, top up only the shortfall, make sure vitamin D is adequate, and put the real effort into leg strength, balance and prescribed medication, which is where the fracture reductions come from.

At a Glance

Common symptoms
Often asymptomatic until a fracture occurs, Loss of height over time, Stooped posture (kyphosis or dowager's hump)
Main treatments
Bisphosphonates (alendronate, risedronate, zoledronic acid) — first-line therapy, Denosumab (RANK ligand inhibitor), Anabolic agents (teriparatide, romosozumab) for severe osteoporosis
Category
Musculoskeletal · About 10 million Americans have osteoporosis; 44 million have low bone density
See a doctor if
Fracture from a low-impact fall or minimal trauma

Symptoms

Often asymptomatic until a fracture occurs
Loss of height over time
Stooped posture (kyphosis or dowager's hump)
Back pain from vertebral compression fractures
Fracture from a fall or even a minor bump
Receding gums and tooth loss (may indicate bone loss)

Causes

  • Imbalance between bone resorption and bone formation favoring net bone loss
  • Declining estrogen levels after menopause (most common cause in women)
  • Aging-related decrease in osteoblast activity
  • Secondary causes: corticosteroid use, hyperthyroidism, hyperparathyroidism, celiac disease

Risk Factors

  • Female sex and postmenopausal status
  • Age over 50
  • Family history of osteoporosis or hip fracture
  • Small, thin body frame
  • Low calcium and vitamin D intake
  • Sedentary lifestyle

Diagnosis

  • Dual-energy X-ray absorptiometry (DEXA) scan measuring bone mineral density
  • FRAX score calculation to assess 10-year fracture risk
  • Blood tests (calcium, vitamin D, thyroid function, parathyroid hormone)
  • Vertebral fracture assessment via lateral spine X-ray or DEXA

Treatment

  • Bisphosphonates (alendronate, risedronate, zoledronic acid) — first-line therapy
  • Denosumab (RANK ligand inhibitor)
  • Anabolic agents (teriparatide, romosozumab) for severe osteoporosis
  • Hormone replacement therapy (for menopausal women with other indications)
  • Adequate calcium (1,200 mg/day) and vitamin D (800–1,000 IU/day) supplementation
  • Weight-bearing and resistance exercises

Natural remedies for osteoporosis: what the evidence says

Ranked by the strength of human evidence for osteoporosis specifically. These sit alongside medical care, not in place of it.

  1. A Lancet meta-analysis of 29 trials in 63,897 people over 50 found calcium, mostly with vitamin D, reduced fractures by 12%, and by 24% in those who took it reliably, with the largest effect at 1,200 mg plus 800 IU vitamin D in people starting from low intake. The Women's Health Initiative, in replete women, raised hip density 1% without significantly cutting fractures and increased kidney stones by 17%, so benefit depends on starting short.

    Studied dose
    1,000 to 1,200 mg a day total from food plus supplements, in doses of 500 mg or less; citrate if you take an acid blocker, carbonate with meals otherwise.
    Cautions
    Separate by 2 hours from levothyroxine, iron and quinolone or tetracycline antibiotics, and take alendronate 30 minutes before any calcium. Thiazides plus calcium can cause hypercalcemia; avoid supplements with kidney stones or hyperparathyroidism, and note some analyses link supplemental calcium to more heart attacks.
  2. Vitamin D3

    Strong evidence

    Vitamin D is needed to absorb calcium and keeps fall-preventing muscles working. In a pooled analysis of 11 trials with 31,022 older adults, those actually taking 800 to 2,000 IU a day had 30% fewer hip fractures and 14% fewer non-vertebral fractures, and 700 to 1,000 IU daily cut falls by 19%. The 2022 VITAL trial of 2,000 IU in replete healthy adults found no fracture reduction, so the gain is in people who are low, older or housebound.

    Studied dose
    800 to 1,000 IU vitamin D3 daily (up to 2,000 IU if deficient), aiming for a 25-hydroxyvitamin D around 30 ng/mL (75 nmol/L).
    Cautions
    Avoid annual megadoses (500,000 IU once yearly increased falls and fractures). Caution with sarcoidosis, hypercalcemia and kidney stones; monitor calcium on thiazides or digoxin.
  3. Vitamin K2 (menaquinone)

    Moderate evidence

    Vitamin K activates osteocalcin, which binds calcium into bone. Japanese trials of prescription-dose MK-4 (45 mg a day) cut vertebral fractures by about 60% in a seven-trial meta-analysis, but a later 4,000-woman trial found no overall benefit. For supplement users the relevant data is a three-year Dutch trial in 244 postmenopausal women in which 180 mcg of MK-7 daily slowed loss of spine and femoral-neck density versus placebo, a 1 to 2% effect with no fracture data.

    Studied dose
    180 mcg MK-7 daily with a fat-containing meal (the Dutch trial dose); 45 mg MK-4 three times daily is a prescription regimen in Japan.
    Cautions
    Contraindicated with warfarin, which it directly reverses; not an issue with apixaban or rivaroxaban. Safe with bisphosphonates and denosumab.
  4. Collagen peptides

    Preliminary evidence

    Collagen is 90% of the bone matrix. In the one randomized trial, 131 postmenopausal women with low bone density took 5 g of a specific collagen peptide or placebo daily for 12 months: spine density rose about 3% and femoral neck about 1% versus a decline on placebo. A four-year open-label extension showed continued gains, but this remains a single manufacturer-sponsored trial with no fracture data.

    Studied dose
    5 g specific bioactive collagen peptides in water once daily for at least 12 months.
    Cautions
    Bovine or fish derived, so unsuitable for vegans and fish allergy. No drug interactions known.
  5. Magnesium

    Preliminary evidence

    About 60% of body magnesium sits in bone, and higher dietary magnesium tracks with higher density in large cohorts. Trials are thin: a two-year Israeli study of 250 to 750 mg a day raised density 1 to 8% in 22 of 31 postmenopausal women, and a 30-day Turkish trial of 290 mg suppressed bone turnover in 20 women. No fracture trial exists.

    Studied dose
    250 to 350 mg elemental magnesium (glycinate or citrate) daily, bringing total intake to about 320 mg for women and 420 mg for men.
    Cautions
    Separate from oral bisphosphonates by at least 2 hours, since magnesium blocks their absorption. Diarrhea at higher doses; avoid with reduced kidney function.
  6. Strontium

    Preliminary evidence

    A warning more than a recommendation. Prescription strontium ranelate cut vertebral fractures by 41% and hip fractures by 36% in high-risk women in two large trials, but was restricted in Europe in 2014 and later withdrawn because it raised heart attack risk by about 60% and increased blood clots. Over-the-counter strontium citrate has never been tested for fractures, and because strontium absorbs more X-ray than calcium, roughly half of the DEXA rise it produces is an artifact.

    Studied dose
    Not recommended. If used, 340 to 680 mg elemental strontium citrate daily, 2 hours apart from calcium, with your doctor aware so DEXA results can be read correctly.
    Cautions
    Avoid with any history of heart attack, angina, stroke, uncontrolled hypertension or blood clots, and in kidney impairment. Competes with calcium for absorption.
  7. Omega-3 (EPA/DHA)

    Preliminary evidence

    Omega-3 fats reduce the cytokines that drive osteoclasts, and in the Framingham cohort higher fish intake went with less hip bone loss over four years. The trials are small and old: 65 older women given EPA and GLA with calcium for a year gained about 3% spine density while controls lost about 3%, and a six-month trial in 79 postmenopausal women found 1,000 mg of omega-3 plus walking raised density more than either alone. No fracture outcomes exist.

    Studied dose
    1 g combined EPA and DHA daily with food, alongside adequate calcium.
    Cautions
    Additive bleeding effect with warfarin, direct anticoagulants and aspirin; stop a week before surgery.
  8. Boron

    Preliminary evidence

    Boron influences how the body handles calcium, magnesium and vitamin D. The evidence is one 1987 USDA study in which 12 postmenopausal women on a boron-depleted diet, then given 3 mg a day, cut urinary calcium loss by 44% and roughly doubled serum estradiol. There are no density or fracture trials.

    Studied dose
    3 mg daily was the studied dose; a plant-rich diet supplies 1 to 3 mg.
    Cautions
    Toxic above about 20 mg a day. May raise estrogen, so avoid supplements after an estrogen-sensitive cancer.

What matters day to day

  • Lift heavy under supervision. In the LIFTMOR trial, 30 minutes of high-intensity resistance and impact training twice a week for eight months raised spine density 2.9% in postmenopausal women with low bone mass, while controls doing gentle exercise lost 1.2%, with no training fractures.
  • Train balance to prevent the fall. Structured balance and functional exercise such as tai chi or the Otago program cuts the rate of falls in older adults by about 23% in Cochrane analysis, and falls cause more than 90% of hip fractures.
  • Eat 1.0 to 1.2 g of protein per kilogram a day. Older adults with higher protein intake lose less hip bone and recover better after fracture; protein is half of bone's structure and works only alongside adequate calcium.
  • Count dietary calcium before buying tablets. Three servings of dairy or fortified alternatives supply about 900 mg; sardines with bones, calcium-set tofu, kale and almonds fill the rest, and food calcium carries none of the kidney-stone risk of supplements.
  • Stop smoking and keep alcohol under two drinks a day. Current smoking raises hip fracture risk 30 to 40% and blunts treatment response; three or more drinks a day roughly doubles fracture risk through bone loss and falls.
  • Audit your medicines. Prednisone at 7.5 mg or more for over three months, proton-pump inhibitors, aromatase inhibitors, androgen deprivation, SSRIs, thiazolidinediones and excess thyroid hormone all accelerate bone loss, and the dose or alternative can often be adjusted.

Prevention

  • Engage in regular weight-bearing and muscle-strengthening exercises
  • Ensure adequate calcium and vitamin D intake through diet and supplementation
  • Avoid smoking and excessive alcohol consumption
  • Undergo bone density screening as recommended (women at 65, men at 70, or earlier with risk factors)
  • Fall prevention strategies including home safety modifications

When to See a Doctor

  • Fracture from a low-impact fall or minimal trauma
  • Loss of height or developing a stooped posture
  • Back pain that may indicate a vertebral fracture
  • Postmenopausal or age-related risk factors warranting bone density screening

Frequently Asked Questions

References

  1. Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet (2007)
  2. Jackson RD, LaCroix AZ, Gass M, et al. (Women's Health Initiative Investigators). Calcium plus vitamin D supplementation and the risk of fractures. New England Journal of Medicine (2006)
  3. LeBoff MS, Chou SH, Ratliff KA, et al.. Supplemental vitamin D and incident fractures in midlife and older adults. New England Journal of Medicine (2022)
  4. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Archives of Internal Medicine (2006)
  5. Knapen MH, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporosis International (2013)
  6. König D, Oesser S, Scharla S, Zdzieblik D, Gollhofer A. Specific collagen peptides improve bone mineral density and bone markers in postmenopausal women: a randomized controlled study. Nutrients (2018)
  7. Meunier PJ, Roux C, Seeman E, et al.. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. New England Journal of Medicine (2004)
  8. Watson SL, Weeks BK, Weis LJ, Harding AT, Horan SA, Beck BR. High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial. Journal of Bone and Mineral Research (2018)
  9. Black DM, Rosen CJ. Postmenopausal osteoporosis. New England Journal of Medicine (2016)
  10. NIH Office of Dietary Supplements. Calcium: Fact Sheet for Health Professionals (2024)View source

Related Conditions

Related from the Supplement Library

These supplements have been studied in relation to Osteoporosis. Always consult your healthcare provider before starting any supplement, especially if you take medications.

Have questions about Osteoporosis?

Ask Mother Nature AI for personalized, evidence-based guidance.

Medical Disclaimer: This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider.

Content reviewed against peer-reviewed medical literature and clinical guidelines. Read our editorial standards.